Concepedia

Author

Rebecca Patenia

The University of Texas MD Anderson Cancer Center

Also Known As

R Patenia, R. PATENIA, R. Patenia, REBECCA PATENIA, Rebecca Patenia, Rebecca S Patenia

55

Publications

736

Citations

15

H-Index

46

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterCharles UniversityFred Hutch Cancer CenterTemple University
RP

About

Rebecca Patenia is an author at The University of Texas MD Anderson Cancer Center specializing in immunology, medicine, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

12

429

2

Cell Biology

6

6

174

3

Natural Sciences

1

1

16

4

Biochemistry

1

1

16

5

Cellular Therapies

1

1

13

Rebecca Patenia

×

20

Publications

714

Citations

15

H-Index

YearCitations

Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.

Ralph S. Freedman, Andrzej P. Kudelka, J. J. Kavanagh,

PubMed

2000

94

Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease

Xipeng Wang, Michael T. Deavers, Rebecca Patenia,

Journal of Translational Medicine

2006

83

HLA Class I Expression on Human Ovarian Carcinoma Cells Correlates with T-Cell Infiltrationin Vivoand T-Cell Expansionin Vitroin Low Concentrations of Recombinant Interleukin-2

Sjarlot Kooi, Hua‐Zhong Zhang, Rebecca Patenia,

Cellular Immunology

1996

73

Reduced Graft-versus-Host Disease in C3-Deficient Mice Is Associated with Decreased Donor Th1/Th17 Differentiation

Qing Ma, Dan Li, Roza Nurieva,

Biology of Blood and Marrow Transplantation

2012

56

Comparative Analysis of Peritoneum and Tumor Eicosanoids and Pathways in Advanced Ovarian Cancer

Ralph S. Freedman, Ena Wang, Sonia Voiculescu,

Clinical Cancer Research

2007

47

Complement component C3 mediates Th1/Th17 polarization in human T-cell activation and cutaneous GVHD

Qing Ma, D. Li, Roberto Carreño,

Bone Marrow Transplantation

2014

43

14-3-3 zeta protein secreted by tumor associated monocytes/macrophages from ascites of epithelial ovarian cancer patients

Ryûji Kobayashi, Michael T. Deavers, Rebecca Patenia,

Cancer Immunology Immunotherapy

2008

40

Activity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo

Hong He, Kathryn Ruisaard, Lisa S. St. John,

Leukemia

2016

37

Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinoma.

Mary E. Gordinier, Hua Zhong Zhang, Rebecca Patenia,

PubMed

1999

34

Broad Cross-Presentation of the Hematopoietically Derived PR1 Antigen on Solid Tumors Leads to Susceptibility to PR1-Targeted Immunotherapy

Gheath Alatrash, Elizabeth A. Mittendorf, Pariya Sukhumalchandra,

The Journal of Immunology

2012

30

Page 1